A detailed history of Allworth Financial LP transactions in Vericel Corp stock. As of the latest transaction made, Allworth Financial LP holds 116 shares of VCEL stock, worth $6,755. This represents 0.0% of its overall portfolio holdings.

Number of Shares
116
Previous 116 -0.0%
Holding current value
$6,755
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

SELL
$31.69 - $39.25 $1,299 - $1,609
-41 Reduced 26.11%
116 $3,000
Q1 2023

Apr 18, 2023

BUY
$23.85 - $31.34 $977 - $1,284
41 Added 35.34%
157 $4,000
Q1 2019

May 07, 2019

BUY
$16.23 - $20.29 $1,882 - $2,353
116 New
116 $2,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.75B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.